Taking aim at disease

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus
ORNL radioisotope manufacturing coordinator Jillene Sennon-Greene places a shipment vial of actinium-225 inside the dose calibrator to confirm its activity is within customer specifications. (Photo: Carlos Jones/ORNL, DOE)

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.

That tiny amount of the radioisotope was purchased by the hospital for use in cancer studies. And it heralded a new peacetime mission for ORNL, built just a few years earlier for the production of plutonium from uranium for the Manhattan Project.

To continue reading, log in or create a free account!

Related Articles

The top 10 states of nuclear

January 16, 2026, 3:00PMNuclear NewsNuclear News Staff

The past few years have seen a concerted effort from many U.S. states to encourage nuclear development. The momentum behind nuclear-friendly policies has grown considerably, with many states...

INL to host Center for Used Fuel Research

January 15, 2026, 12:35PMNuclear News

The Department of Energy’s Office of Nuclear Energy announced the establishment of the Center for Used Fuel Research (CUFR), to be hosted at the Idaho National Laboratory and focused on...